Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


GREY:CTABF - Post by User

Comment by Fizzy1985on Apr 21, 2018 7:24am
92 Views
Post# 27921125

RE:Confused

RE:ConfusedI think that’s exactly why this crashed so hard...people knew that $4 was overpriced to start so they shorted the stock and since most  people were down so much money they just market sold all their shares. I could be wrong but I remember being in TFS and selling at 3.5 cents because I didn’t think the stock would open at 7 bucks...I think that for new buyers this is a steal and will be next week also because most shareholders will sell their « «worthless » shares... I do think though that when the deal in Australia becomes 100% official which was supposed to be in Q2 and then the EMC deal that this could hit anywhere above 2 bucks as that would be a 50 Mil market cap... so for newbies getting in, i think there are big gains to be made and in a short period of time. And if for some fluke of a chance these pills become a big thing well then an 75 to 100 Mil market cap makes sense. Who knows, let’s see what next week brings...all I’m saying is that 4 dollars a share is 100 mil market cap, which could be achieved eventually...
<< Previous
Bullboard Posts
Next >>
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse